Last year the Braemar Charitable funded research through its Memorandum of Understanding with the Waikato Medical Research Foundation that focused on "Outcomes following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for appendiceal pseudomyxoma and colorectal peritoneal carcinomatosis at Te Whatu Ora Waikato and Braemar Hospital. Assessing the outcomes following CRS and HIPEC treatment and factors predictive of perioperative morbidity and long-term survival will contribute to the ongoing quality improvement of the CRS and HIPEC service. This could further augment patient outcomes by streamlining patient selection, protocolising national referral processes, raising awareness among service users and clinicians, and addressing ethnic and geographic inequities. The project will also yield substantial healthcare delivery and workforce development benefits to the Waikato region by establishing the Waikato region as a national centre of excellence in peritoneal surface malignancy. This project could also yield equity benefits to Māori and Pasifika. Inequities in cancer treatment and survival have been widely observed between Māori and non-Māori patients. Dr Rennie Quin under the supervision of Medical Trustee Jasen Ly will complete her Braemar-funded oncology study later this year. Together they presented the preliminary data to the Royal Australasian College of Surgeons meeting and received a prize for the best presentation in surgical oncology. Their abstract has also been accepted as a poster of exceptional merit at the American College of Surgeons meeting.
